Bio

Dr. Sachin Rajpal is an ophthalmologist at Stanford Health Care. He is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.

Dr. Rajpal specializes in cataract surgery and minimally invasive glaucoma surgery (MIGS). He also focuses on the medical and surgical management of pterygium (growths on the white of the eye) and ocular (eye) surface disease. His approach emphasizes comprehensive, patient-centered care, combining clinical excellence with clear communication and individualized treatment planning. He is particularly passionate about improving access to surgical care and enhancing the patient experience through the thoughtful application of emerging technology.

His research interests include patient adoption of digital diagnostic tools, technology-driven vision testing, and the development and regulation of leading-edge ophthalmic devices. He is also part of the Stanford Medicine Byers Eye Institute team working on a whole-eye transplant project focusing on vision restoration. Dr. Rajpal is actively involved in translational research that bridges clinical needs with scalable solutions.

Dr. Rajpal’s work has been presented at major conferences, including the Association for Research in Vision and Ophthalmology, American Society of Refractive and Cataract Surgery, and American Academy of Ophthalmology (AAO). He has authored peer-reviewed studies on topics ranging from corneal melt (corneal breakdown) to divergence insufficiency (outward vision problems), wearable visual field testing, and economic models of ocular disease burden.

Clinical Focus

  • Ophthalmology

Academic Appointments

  • Clinical Instructor, Ophthalmology

Administrative Appointments

  • Founder and President, Chapter of the Washington DC Metropolitan Ophthalmological Society (2023 - 2024)

Honors & Awards

  • Chief Resident, Department of Ophthalmology, Howard University Hospital
  • Byers Eye Ophthalmology Innovation Fellow, Stanford University School of Medicine
  • Resident Physician Representative, Graduate Medical Education Committee, Howard University Hospital

Professional Education

  • Residency: Howard University Hospital GME Verifications (2024) DC
  • Internship: Howard University Hospital GME Verifications (2021) DC
  • Medical Education: Howard University College of Medicine (2020) DC

Contact

  • Academic
    srajpal@stanford.edu
    Department: Ophthalmology Clinic and Education Position: Clinical Instructor
  • Clinical (Primary)  Stanford Byers Eye Institute 2452 Watson Ct Palo Alto, CA 94303 (650) 725-6619 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5353

All Publications

  • Evaluation of Patient Acceptance for Visual Field Testing with a Wearable Device Rajpal, S., Durbin, M., Nicklin, A., Spencer, B., Lopez, V., Sanchez, S., Sanchez, R., Williams, D., Tagayun, C., Abou Shousha, M. ASSOC RESEARCH VISION OPHTHALMOLOGY INC. 2022

    View details for Web of Science ID 000844401303254

  • Corneal melt in a patient with rheumatoid arthritis on methotrexate and tofacitinib Nguyen , N., Ling C, W., Brown , D., Rajpal , S., Markidan , J., Michael , M. Edorium J Ophthalmol. 2022 5–10
  • Thyroid Eye Disease With Divergence Insufficiency Causing Recurrent Falls in an Elderly Patient. Cureus Lai, W. C., Nguyen, N. S., Husain, A., Rajpal, S. D., Michael, M. B. 2022; 14 (1): e21695

    Abstract

    Recurrent falls are a common cause of morbidity in the elderly population, as more than one-third of individuals aged 65 years or older experience falls each year. Falls remain a multifactorial phenomenon that can potentially result in devastating debilitation and hence require proper medical attention and management. In an elderly patient presenting with recurrent falls, the workup for differential diagnoses remains wide with various causes such as postural hypotension, syncope, seizures, arrhythmia, medication-induced, and cognitive impairment. In this report, we discuss an interesting case of recurrent falls in an elderly woman with hyperthyroidism who was repeatedly found to have unremarkable lab results and negative imaging studies. She was later diagnosed with divergence insufficiency with intermittent esotropia secondary to thyroid ophthalmopathy, which was the cause of her underlying horizontal diplopia contributing to her falls. This can cause blurry vision at further distances, which is observed especially in individuals older than 50 years. Treatment typically involves prism therapy, surgery in refractory patients, and, currently, novel therapy using teprotumumab infusion. The patient was referred to see a strabismus specialist for prism prescription and possible surgical intervention. In elderly patients with a history of recurrent falls, a comprehensive visual exam should be strongly considered, especially for individuals with repeated negative workups, to prevent further testing or procedures.

    View details for DOI 10.7759/cureus.21695

    View details for PubMedID 35237487

    View details for PubMedCentralID PMC8882349

  • The burden of respiratory syncytial virus infections in infants in the United States Ektare , V., Botteman , M., Rajpal , S., Simoes , E. Proceedings of the National Academy of Sciences. 2016
  • Lasik Xtra® Provides Corneal Stability and Improved Outcomes OPHTHALMOLOGY AND THERAPY Rajpal, R. K., Wisecarver, C. B., Williams, D., Rajpal, S. D., Kerzner, R., Nianiaris, N., Lytle, G., Hoang, K. 2015; 4 (2): 89-102

    View details for DOI 10.1007/s40123-015-0039-x

    View details for Web of Science ID 000218781500003

  • Warning: You are about to be nudged Loewenstein , G., Bryce , C., Hagmann , D., Rajpal , S. Behavioral Science & Policy. 2015 35–42
  • The economic burden of retinopathy of prematurity Clarke , N., Botteman , M., Rajpal , S. Abstract submitted. 2015
  • A comprehensive economic model of the clinical burden of respiratory syncytial virus Manuscript in preparation Ektare , V., Botteman , M., Rajpal , S., OCampo , R. 2015
  • Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence. Patient preference and adherence Rajpal, R. K., Ross, B., Rajpal, S. D., Hoang, K. 2014; 8: 925-31

    Abstract

    Ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used by clinicians to manage ocular inflammation and pain following cataract surgery. Over the past decade, the US Food and Drug Administration has approved multiple topical NSAIDs for these purposes, including several reformulated products. One of these medications, bromfenac ophthalmic solution, has a long and extensive history, with proven efficacy and safety in patients following cataract surgery. The evolution of bromfenac ophthalmic solution over the years has involved either lowering the concentration of the active ingredient or extending the dosing interval to improve patient adherence/compliance. This review will focus on the history and progression of bromfenac ophthalmic solution and report the available patient preference and adherence data regarding this ocular NSAID throughout its evolution.

    View details for DOI 10.2147/PPA.S46667

    View details for PubMedID 25028541

    View details for PubMedCentralID PMC4077855